RE:Moribund share priceIMO, the split does nothing for the stock valuation. What will impact the evaluation is financial performance by the companies. We can expect to hear some updates on progress in this area in January. I also expect Viemed executives will be telling their story to more institutional investors. Its not clear if Crawford has any plans on this front however we can expect the new PHM to make some acquisitions in early 2018 and possibly more later in the year. Crawford has been communicating this for some time. We just went through a "blackout" period of any relevant information to excite investors. That period is over. The old PHM build a stock base around 13 15 cents and turned into a solid double for investors back then. We now have a solid valuation base of 30 to 32 cents and I expect the current investors will see more than a double on their investment over the next year and even more the following year. $1 handle is not that far into the future so I continue to believe this is a solid investment and I hold a solid position in the company. Was a buyer in the 13 to 15 cent range and have been rewarded well for the investment. I also added in the 20's and low 30's and expect these investments will be just as good over the next year or two.